There is no product in the shopping cart, buy it!
| Size | Qty | Add To Basket |
|---|---|---|
| 1 mg | ||
| 2 mg | ||
| 5 mg |
| Product Overview | Recombinant Human F11 protein (NP_000119.1) is produced in Sia-Increased Human Cell Lines. This expression system is used for the production of glycoproteins with high sialylation and core fucosylation. |
| Source | Sia-Increased Human Cell Lines |
| Species | Human |
| Tag | His-tag, FC-tag |
| Purity | >90%, determined by SDS-PAGE. |
| Endotoxin Level | Regular batch |
| Conjugation | None |
| Target | F11 |
| Full Name | Coagulation factor XI |
| Gene ID | 2160 |
| Uniprot ID | P03951 |
| Accession Number | NP_000119.1 |
| Background | This gene encodes coagulation factor XI of the blood coagulation cascade. This protein is present in plasma as a zymogen, which is a unique plasma coagulation enzyme because it exists as a homodimer consisting of two identical polypeptide chains linked by disulfide bonds. During activation of the plasma factor XI, an internal peptide bond is cleaved by factor XIIa (or XII) in each of the two chains, resulting in activated factor XIa, a serine protease composed of two heavy and two light chains held together by disulfide bonds. This activated plasma factor XI triggers the middle phase of the intrisic pathway of blood coagulation by activating factor IX. Defects in this factor lead to Rosenthal syndrome, a blood coagulation abnormality. |
| Alternate Names | FXI |